Bavarian Nordic wins positive CHMP opinion to amend Imvanex approval
The European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has recommended adjusting the marketing authorisation of Bavarian…
The European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has recommended adjusting the marketing authorisation of Bavarian…
The UK Medicines and Healthcare products Regulatory Agency (MHRA) has authorised the use of Pfizer-BioNTech’s adapted Comirnaty vaccine to combat…
Gilead received a standing ovation after announcing its full, perfect efficacy data from the Phase III PURPOSE 1 trial of…
The UNAIDS executive director has called upon Gilead Sciences to make its ‘miracle’ drug lenacapavir for human immunodeficiency virus (HIV)…
The US Department of Health and Human Services (HHS) has exercised a procurement option for SIGA Technologies’ oral Tpoxx (tecovirimat).…
Researchers will present data from a ‘first-of-its-kind HIV cure’ stem cell transplant at the upcoming AIDS 2024 Conference. Experts will…
Meitheal Pharmaceuticals has expanded its biopharmaceutical portfolio through the acquisition of rights to CONTEPO (fosfomycin for injection) from Nabriva Therapeutics…
Nestled between J P Morgan’s London headquarters and the Mastercard office in Canary Wharf, London, is an unassuming building that…
GSK and Medicines for Malaria Venture (MMV) have announced the launch of a new single-dose medicine, tafenoquine, to prevent the…
Emergent BioSolutions has received contract modifications worth more than $250m from the US Department of Health and Human Services (HHS)…